2015
DOI: 10.1016/j.ejpb.2015.07.018
|View full text |Cite
|
Sign up to set email alerts
|

Bioadhesive vaginal drug delivery of nystatin using a derivatized polymer: Development and characterization

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
19
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 44 publications
(20 citation statements)
references
References 47 publications
(29 reference statements)
1
19
0
Order By: Relevance
“…Although Mo -CBP 2 is toxic to Candida spp., this protein did not cause hemolysis in human and rabbit erythrocytes, even in the highest concentration tested (1000 μg/mL). Despite the nystatin effectiveness as antifungal agent and prescription in superficial candidiasis treatment, its clinical use is limited due to its toxicity to human erythrocytes (Bassi and Kaur, 2015). Melittin, other potent antimicrobial peptide against Candida spp., causes hemolysis in human blood cells even in low concentrations, which limits its use in antifungal therapy (Lee and Lee, 2015; Lee et al, 2015).…”
Section: Discussionmentioning
confidence: 99%
“…Although Mo -CBP 2 is toxic to Candida spp., this protein did not cause hemolysis in human and rabbit erythrocytes, even in the highest concentration tested (1000 μg/mL). Despite the nystatin effectiveness as antifungal agent and prescription in superficial candidiasis treatment, its clinical use is limited due to its toxicity to human erythrocytes (Bassi and Kaur, 2015). Melittin, other potent antimicrobial peptide against Candida spp., causes hemolysis in human blood cells even in low concentrations, which limits its use in antifungal therapy (Lee and Lee, 2015; Lee et al, 2015).…”
Section: Discussionmentioning
confidence: 99%
“…The dosage form needs to reside at the site of infection for a prolonged period. These limitations can be overcome by a drug delivery system because of portability, convenient application, long retention time, easy storage and handling and improved stability [18].…”
Section: Introductionmentioning
confidence: 99%
“…In the past two decades, there has been growing research interest in developing new drug formulations that are more accepted by patients, by reducing the frequency of doses and improving the organoleptic properties, in particular regarding the use of nys to treat oral candidiasis [18,[31][32][33][34][35][36].…”
Section: Introductionmentioning
confidence: 99%